Vicarious Surgical Management
Management criteria checks 3/4
Vicarious Surgical's CEO is Adam Sachs, appointed in Jan 2014, has a tenure of 10.92 years. total yearly compensation is $3.13M, comprised of 17.1% salary and 82.9% bonuses, including company stock and options. directly owns 6.75% of the company’s shares, worth $4.85M. The average tenure of the management team and the board of directors is 3.3 years and 3.3 years respectively.
Key information
Adam Sachs
Chief executive officer
US$3.1m
Total compensation
CEO salary percentage | 17.1% |
CEO tenure | 10.9yrs |
CEO ownership | 6.8% |
Management average tenure | 3.3yrs |
Board average tenure | 3.3yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate
Nov 30Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely
Aug 16Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Mar 05Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?
Nov 24Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization
Aug 24Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation
Jul 18Vicarious Surgical: Cash Burn Adds To Downside Risk
May 26Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02
Feb 13Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03
Nov 07Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02
Aug 08Vectoring In On Vicarious Surgical Inc.
Jun 23Vicarious Surgical: Developing Minimally Invasive VR Surgical System
Nov 29CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$62m |
Jun 30 2024 | n/a | n/a | -US$61m |
Mar 31 2024 | n/a | n/a | -US$61m |
Dec 31 2023 | US$3m | US$537k | -US$71m |
Sep 30 2023 | n/a | n/a | -US$69m |
Jun 30 2023 | n/a | n/a | -US$78m |
Mar 31 2023 | n/a | n/a | -US$64m |
Dec 31 2022 | US$5m | US$531k | US$5m |
Sep 30 2022 | n/a | n/a | US$38m |
Jun 30 2022 | n/a | n/a | US$18m |
Mar 31 2022 | n/a | n/a | US$13m |
Dec 31 2021 | US$6m | US$268k | -US$35m |
Sep 30 2021 | n/a | n/a | -US$61m |
Jun 30 2021 | n/a | n/a | -US$19m |
Mar 31 2021 | n/a | n/a | -US$15m |
Dec 31 2020 | US$187k | US$180k | -US$13m |
Compensation vs Market: Adam's total compensation ($USD3.13M) is above average for companies of similar size in the US market ($USD653.16K).
Compensation vs Earnings: Adam's compensation has been consistent with company performance over the past year.
CEO
Adam Sachs (32 yo)
10.9yrs
Tenure
US$3,134,667
Compensation
Mr. Adam David Sachs is Co-Founder at Vicarious Surgical Inc. in 2014. He serves as Chief Executive Officer and Director of Vicarious Surgical Inc. (Formerly, D8 Holdings Corp.) since September 2021. He se...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 10.9yrs | US$3.13m | 6.75% $ 4.8m | |
Co-founder | 3.3yrs | US$1.82m | 2.85% $ 2.0m | |
CFO & Treasurer | 3.3yrs | US$1.64m | 0.028% $ 20.4k | |
President | less than a year | no data | no data | |
Co-founder & Chief Medical Officer | no data | no data | 2.2% $ 1.6m | |
Chief Operating Officer | 2.9yrs | no data | 0.053% $ 37.8k | |
Head of Legal & Secretary | no data | no data | no data | |
Vice President of Business Operations & People | 3.3yrs | no data | no data |
3.3yrs
Average Tenure
49yo
Average Age
Experienced Management: RBOT's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 3.3yrs | US$3.13m | 6.75% $ 4.8m | |
Co-founder | 3.3yrs | US$1.82m | 2.85% $ 2.0m | |
Independent Director | 2.2yrs | US$196.56k | 0.078% $ 55.7k | |
Independent Director | 3.3yrs | US$195.77k | 0.063% $ 45.4k | |
Independent Director | 3.3yrs | US$198.45k | 0.15% $ 108.8k | |
Independent Director | 1.9yrs | US$447.60k | 0.054% $ 38.6k | |
Independent Director | 3.3yrs | US$185.14k | 0.71% $ 508.4k |
3.3yrs
Average Tenure
49yo
Average Age
Experienced Board: RBOT's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 07:32 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vicarious Surgical Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Gorman | BTIG |
Matthew Miksic | Credit Suisse |
Adam Maeder | Piper Sandler Companies |